GlassScriptPhysician profile
Deborah Anne Young
NPI 1619969821
$1,190.51
in general payments reported to CMS, 2019-2025
17 companies · $244 in 2025
The $244 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226 · 2020: $19.77 · 2022: $115 · 2023: $267 · 2024: $319 · 2025: $244.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $810 · Long Term Medical Supply Or Device Loan: $19.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $810.03 |
| Long Term Medical Supply Or Device Loan | $19.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $349.53 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Abbvie INC. | $114.58 | 2023-2025 | Qulipta, Vraylar |
| Astrazeneca Pharmaceuticals LP | $107.57 | 2019-2025 | Farxiga, Airsupra |
| Lilly USA, LLC | $99.96 | 2019-2025 | Mounjaro, Zepbound |
| Glaxosmithkline, LLC. | $82.94 | 2019-2023 | Arexvy, Trelegy Ellipta |
| Astellas Pharma US INC | $59.31 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $54.29 | 2019-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.14 | 2023-2024 | Jardiance |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $48.76 | 2025 | Xifaxan |
| Amgen INC. | $45.67 | 2019-2025 | Repatha, Otezla |
| Abbott Laboratories | $44.37 | 2024 | Freestyle Libre 3, Freestyle Insulinx |
| Merck Sharp & Dohme LLC | $34.99 | 2023 | Varivax, Proquad, Gardasil 9 |
| Otsuka America Pharmaceutical, INC. | $28.23 | 2023 | Rexulti |
| Exact Sciences Corporation | $24.54 | 2023 | Cologuard Collection Kit |
| Sanofi Pasteur INC. | $19.54 | 2024 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $11.25 | 2019 | |
| Sanofi-Aventis U.S. LLC | $10.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deborah Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.